Top 3 Dividend Stocks for Long-Term Investing in the Next 10 Years

When it comes to investing, finding the right stocks to hold for the long term and pay attractive dividends can be a winning strategy. In this blog post, we will discuss three dividend stocks that our experts at Extreme Investor Network recommend buying and holding for the next decade: AbbVie, Eli Lilly, and Pfizer.

AbbVie (NYSE: ABBV) is a pharmaceutical company that has been consistently increasing its dividend payouts since it split from Abbott Laboratories. Despite losing patent protection for its top product, Humira, AbbVie has continued to hike its dividends and has a solid underlying business. With products like Skyrizi, Botox, and migraine treatments in its portfolio, AbbVie is poised for revenue growth in the future. As a Dividend King with 52 consecutive years of dividend increases, AbbVie offers a forward yield of 3.69% and plenty of room for further growth.

Related:  Canaccord's Tony Dwyer: Federal Reserve Needs to Lower Rates More Aggressively to Address Job Concerns

Eli Lilly (NYSE: LLY) may have a modest dividend yield of 0.7%, but the company has doubled its dividend over the past five years. With diabetes and weight loss drugs like Mounjaro and Zepbound in its pipeline, Eli Lilly has strong growth prospects that could lead to significant revenue in the future. By investing in Eli Lilly, you can benefit from both dividend income and potential stock valuation growth.

Pfizer (NYSE: PFE) is another dividend stock that our experts recommend for long-term investors. With a dividend yield of over 6.6% and a commitment to increasing its dividend every year, Pfizer appeals to both income and value investors. Despite challenges such as declining COVID-19 product sales and upcoming patent expirations, Pfizer’s business development deals and revenue-generating potential make it a compelling investment for the future.

Related:  Elon Musk Terminates Deal To Buy Twitter; Board To Pursue Legal Action

In conclusion, choosing the right dividend stocks to buy and hold for the next decade requires careful consideration of the company’s financial health, growth prospects, and dividend history. By investing in companies like AbbVie, Eli Lilly, and Pfizer, you can potentially build a strong portfolio that generates passive income and long-term growth. Stay tuned to Extreme Investor Network for more insights and recommendations on dividend investing strategies.

Source link